This is one of the most common pressures we hear. The technology landscape is moving faster than most regulated device organizations can track internally: AI models update frequently, cybersecurity requirements evolve constantly, and connectivity and integration standards continue to shift. Suntra acts as an extension of the CTO function for our clients, continuously monitoring emerging platforms, regulatory updates, and interoperability standards, and translating that into actionable guidance your team can actually use. Get to know the leadership team behind this approach.

Obsolescence risk is real and underappreciated in medtech. What was compliant and secure one year may create vulnerabilities or interoperability issues the next. Suntra benchmarks each client's technology stack against current best practices on an ongoing basis, identifying modernization opportunities before they become urgent problems. We guide teams through those transitions in a way that preserves compliance and keeps development moving. Learn how we approach innovation and risk management.

Yes. Software as a medical device and AI-enabled products are areas where roadmaps built on traditional device development cycles consistently struggle to keep pace. We bring program governance, agile transformation capabilities, and pre-validated architectures that help teams execute on SaMD and AI programs with the speed and compliance rigor the regulatory environment requires. Explore what it takes to move AI from concept to execution.